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The ability of eukaryotic ribosomes to reinitiate translation at downstream AUG codons on polycistronic 
mRNAs was used to select ransfected CHO clones that secreted a precursor to the human pancreatic poly- 
peptide (PP). In the in vitro constructed transcription unit, a viral promoter directed the synthesis of a dicis- 
tronic mRNA. The PP cDNA was placed in the Y-part of this transcript, while a DHFR cDNA was placed 
3' to the PP. This dicistronic expression unit was transfected into CHO cells, and methotrexate-resistant 
colonies were selected. RNA-blots verified that the PP precursor and DHFR were expressed from the same 
dicistronic mRNA. The CHO cells synthesized the hormone precursor and secreted it through the constituti- 
ve secretory pathway. 
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1. INTRODUCTION 
A growing number of recent investigations sug- 
gests that eukaryotic ribosomes have the capacity 
to reinitiate translation at a downstream (internal) 
AUG, once they have terminated translation of an 
upstream open reading frame [1-3]. The 
hypothesis for translation initiation in eukaryotes 
[4-6] states that the 40 S ribosomal subunit first 
binds at the 5' -capped end of the mRNA. A scan- 
ning mechanism is then suggested, in which the 
40 S subunit migrates [7] through the 
5' -untranslated region until an AUG is reached. In 
approx. 94O7o f 221 inspected eukaryotic mRNAs 
[8] the first AUG encountered by the migrating 
40 S subunit serves as the initiator. Eukaryotic 
ribosomes have a strong preference [5] for in- 
itiating translation at AUGs located in the consen- 
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sus sequence ACCAUGG. When the 40 S subunit 
reaches an AUG in this consensus, the entire 80 S 
ribosome will assemble and initiate translation. In 
the few per cent of eukaryotic mRNAs where 
translation of the encoded protein does not start at 
the 5' -proximal AUG, this is most often correlated 
with the presence of an unfavourable sequence sur- 
rounding this AUG, e.g. if the -3  position con- 
tains a pyrimidine. In these cases the 40 S subunit 
will continue scanning until it reaches internal 
AUGs further downstream. 
In experimentally conceived mRNAs [1-3,9,10] 
it has been demonstrated that initiation at a 
downstream AUG can be severely impaired if this 
AUG is preceded by a favourable upstream AUG. 
If  translation from the 5'-proximal AUG con- 
tinues beyond the downstream AUG, translation 
from the downstream AUG can be totally abolish- 
ed. However, if a terminator codon stops the 
translation initiated at the 5'-proximal AUG 
before it reaches the downstream AUG, the latter 
codon can now serve as a translational start site. 
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Thus termination-reinitiation is a feature of the 
translational process, which is not confined to the 
well-known polycistronic systems in prokaryotes. 
This new realization opens up a reinterpretation f 
data on gene expression from both cellular and 
viral polycistronic mRNAs, where potential inter- 
nal AUG initiation codons are found. 
Termination-reinitiation may also find advan- 
tageous applicability in expression systems design- 
ed for eukaryotic ells. In transfection experiments 
with mammalian cells a selectable genetic marker is 
most often introduced, together with the expres- 
sion system under investigation, into the target 
cells on either a separate plasmid or on the same 
plasmid as the investigated heterologous expres- 
sion system, but under control of a separate pro- 
moter. In the present report we present a new 
strategy for expression vector design. A dicistronic 
transcription unit, which directs synthesis of the 
precursor of human pancreatic polypeptide (PP) 
[11] as well as the synthesis of a selectable genetic 
marker (the mouse DHFR), can be expressed in 
mammalian ceils. 
2. MATERIALS AND METHODS 
2.1. Plasmid constructions 
The plasmids used in this investigation, pPP, 
pDHFRLI and pPP-DHFR ~, were constructed by 
the use of standard techniques [12], and their 
structural elements are described in section 3.1. 
digested with different restriction enzymes before 
electrophoresis on 1070 agarose gels. After 
Southern blot transfer [14] the filters were 
hybridized to a DHFR specific probe labelled by 
nick translation [15]. Total cellular RNA was ex- 
tracted [16] from CHO cell lines and was analysed 
with 32p-nick-translated [15] DHFR- and PP- 
specific DNA probes after electrophoresis in for- 
maldehyde containing agarose gels [12] as de- 
scribed in [17]. 
2.4. Radioimmunoassay of PP 
PP was measured by radioimmunoassay as
described [18] in medium from cell incubations 
directly and in cell extracts. Peptides were ex- 
tracted from pellets of approx. 107 cells by boiling 
for 2 min in 2 ml of 50°7o acetic acid. Total protein 
was determined in the acetic acid extract directly 
by the Bio-Rad, Bradford method [19]. 
2.5. Peptide characterization 
35S-Methionine-labelled peptides were charac- 
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2.2. Cell culture and DNA transfection 
Chinese hamster ovary (CHO) ceils and clones 
derived from this cell line were grown in Dulbec- 
co's modified Eagle's medium supplemented with 
10°70 fetal calf serum at 507o CO2. Plasmid DNA 
was transfected into cells using calcium phosphate 
precipitation [13] and 48 h post-transfection cells 
were split at an approximate 1:8 ratio into new 
media supplemented with methotrexate (0.3/zM 
Mtx). In a typical transfection experiment using 
50°7o confluent cells in a 9 cm culture dish, approx. 
10/~g of plasmid was used. pPP-DHFR r was used 
alone and pPP and pDHFRr-I were used together 
in a 10 : 1 molar ratio. Clones were picked after 10 
days and propagated in media with 0.3/zM Mtx. 
2.3. DNA and RNA extraction and analysis 
DNA was extracted from cell lines and 10/zg was 
pDHFRLI 
pag o, IMLP JL,13~ I ..... [pA F- 
. . . .  ~ 930 + pA 
Fig. 1. The transcription units used in three mammalian 
expression plasmids are shown as a number of open 
boxes each representing a functional unit. Each 
transcription unit was constructed on either pBR322 or 
pML [34]. '0-1' designates 0 to 1 map unit of adenovirus 
5; 'E' is the SV40 early enhancer; 'MLP' is the 
adenovirus 2 (Ad2) major late promoter; 'L 1-3' is the 
tripartite leader from Ad2; '5'ss' is a 5'-splice site; 
'3'ss' is a 3'-splice site; 'pA' is the polyadenylation 
signal from the late transcriptional unit of SV40 in pPP- 
DHFR r and in pPP. In pDHFRr-I the early 
polyadenylation signal is used. pDHFRr-I lacks the SV40 
enhancer and contains only the first Ad2 leader. The 
expected spliced transcript is shown below each DNA 
construction. 
182 
Volume 219, number 1 FEBS LETTERS July 1987 
terized by SDS-gel electrophoresis [20] after im- 
munoprecipitation. Cells in a 90% confluent 
160 cm 2 flask were incubated with 3SS-methionine 
for 4 h in medium lacking methionine. Radio- 
labelled peptides were extracted from the medium 
by Sep-Pak purification. Immunoprecipitation 
was performed in 50 mmol/ l  Tris, pH 7.4, con- 
taining 0.2 mol/1 NaCI, 6 mmol/1 EDTA, 5% 
(v/v) aprotinin solution, and 1.25% (v/v) Triton 
X-100. Two different PP antisera, 2/A for each 
sample, were used for immunoprecipitation: Ab 
146-7, a gift from Dr R.E. Chance (this antiserum 
is known to precipitate the PP precursor [21]), and 
Ab 205, a gift from Dr M.M.T. O 'Hare [22]. After 
20 h of incubation the precipitation was performed 
by protein A-Sepharose and the radiolabelled pep- 
tides were extracted by boiling in the electro- 
phoresis sample mixture. The specificity of the 
immunoprecipitation was tested by parallel ex- 
periments where 50/zg of bovine PP was added. 
Pulse-chase xperiments were performed on cells 
in 2.5 cm petri dishes, incubated for 15 min with 
0.25 mCi of ~SS-methionine each. Radiolabelled 
peptides were isolated from the medium, as 
described above, after different chase periods in 
medium containing unlabelled methionine. 
3. RESULTS 
3.1. PreproPP and DHFR r expression plasmids 
The three adenovirus promoter based expression 
plasmids used in the present study are shown in 
fig.1. In pDHFRr-I  [23], the mouse DHFR cDNA 
has been mutated by oligonucleotide-directed site 
specific mutagenesis to change the Leu-22 to an 
Arg. This mutation gives DHFR the Mtx-resistant 
phenotype [24]. The human preproPP cDNA from 
pHPP165 [11] was isolated as a 570 bp PstI frag- 
ment. pPP was generated by adding BamHI 
linkers to the preproPP encoding fragment which 
was then ligated into the BamHI cloning site of 
pD5. The structure of pD5 is similar to pD11 [25]. 
In pPP-DHFW the promoter directs the synthesis 
of a dicistronic mRNA that encodes both 
preproPP and DHFR r. The Fnu4H I site just 5' to 
the initiator codon of DHFR ~ [24] in pDHFRr-I  
was changed to a BamHI site by linker addition, 
deleting most of the 5'-nontranslated sequences 
from DHFR ~ cDNA. Cells transfected with this 
dicistronic construct can only grow in Mtx, if 
DHFR r is expressed from a transcribed icistronic 
mRNA, which also directs the synthesis of 
preproPP, or if some gene rearrangement has 
taken place that locates the open reading frame of 
DHFR r at a more 5'-position on the mRNA. 
3.2. Isolation of HPP-producing cell fines 
CHO cells were transfected by the calcium 








Fig.2. Autoradiography from blot analysis of CHO cell 
RNA. 40 #g of total cellular RNA was applied to each 
lane on a 1.2°70 formaldehyde agarose gel. After 
electrophoresis the RNA was blotted onto nitrocellulose 
and hybridized with ~2P-nick-translated DHFR r DNA. 
Lanes: A, RNA from nontransfected cells; B, 
bacteriophage DNA digested with HindlIl and labelled 
with 32p; C, RNA from cell line CHO-571 (cotransfected 
with pDHFRr-I and pPP); D, RNA from cell line 
CHO-728 (transfected with pPP-DHFRr). 
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pPP together with pDHFRr-I.  No colonies were 
detected in mock transfected cells grown in 0.3/zM 
Mtx. After 10 days clones could be isolated from 
cells that had been cotransfected with pPP and 
pDHFRr-I as well as from cells transfected with the 
dicistronic construct pPP-DHFW, pPP-DHFR ~ 
gave approximately 20-fold lower cloning efficien- 
cy than pDHFRr-I when an equivalent amount of 
plasmid DNA was used in the transfection ex- 
periments. All colonies generated by this 
dicistronic gene secreted measurable amounts of 
PP immunoreactive p ptides. DNA, RNA and im- 
munoreactive peptides were analysed in a represen- 
tative clone from the cotransfection experiment 
(CHO-571) and in one from the transfection with 
pPP-DHFR ~ (CHO-728). 
3.3. Analysis of DNA and RNA from transfected 
cell lines 
DNA extracted from clones CHO-571 and 
CHO-728 was digested with a number of restric- 
tion enzymes and analysed by Southern blotting 
[14] using 32p-nick-translated DHFR fragments as 
hybridization probes. We could detect no rear- 
rangements in the DNA from CHO-571 nor in the 
DNA from CHO-728 as compared to the structure 
of the introduced expression units (not shown). It 
is possible, however, that splicing events could 
have shifted the DHFR r open reading frame to a 
more 5'-location on a rearranged mRNA molecule 
to generate a monocistronic unit, and we therefore 
carried out Northern blot analysis on extracted 
RNA from the two cell lines, with both DHFR r and 
PP specific probes. In fig.2 the autoradiography 
from a Northern blot on RNA from untransfected 
CHO cells and from the cell lines CHO-571 and 
CHO-728 is shown. In this analysis the RNAs were 
hybridized to a 32p-nick-translated DHFR r restric- 
tion fragment. The 0.95 kb mRNA in lane C cor- 
responds to the DHFR r specific transcript 
synthesized from the pDHFRr-I gene (fig. 1), which 
was used in a cotransfection with pPP to generate 
the cell line CHO-571. The CHO-728 clone was ob- 
tained from a transfection with the dicistronic 
pPP-DHFR ~ alone, and DHFR-specific mRNA 
from this cell line (lane D in fig.2) was 1.6 kb long, 
which is in good agreement with the expected 
length of a dicistronic transcript from the PP- 
DHFW gene (fig.l). In fig.3 the same RNAs were 
analysed for PP-specific transcripts. In lane C a 
LETTERS 




Fig.3. Autoradiography from blot analysis of CHO cell 
RNA. Electrophoresis and RNAs applied to the 
different lanes were as in fig.2. The blot was hybridized 
with 32p-nick-translated PP DNA. 
0.95 kb mRNA is identified, and this size fits well 
with the expected 0.9 kb transcript from the 
monocistronic PP construct (fig.l). In lane D a 
1.6 kb PP specific mRNA is observed, and the size 
of this RNA species corresponds precisely to the 
DHFR ~ specific transcript detected in the same cell 
line (fig.2, lane D). It can be concluded that 
CHO-728 expresses DHFR and PP from the same 
dicistronic 1.6 kb mRNA. 
3.4. Peptide characterization 
In table 1 the amounts of PP stored in and 
secreted from transfected cells are shown. La- 
belling experiments with 35S-methionine showed 
that the PP produced in the CHO cells as judged 
by SDS-gel electrophoresis corresponded in size 
(9.5 kDa) to the PP precursor previously 
characterized (fig.4) [11]. During prolonged in- 
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Table 1 
Pancreatic polypeptide synthesis and secretibn from 
Chinese hamster ovary (CHO) cells transfected with a 
dicistronic vector, pPP-DHFR r, containing both the PP 
and the DHFR coding sequences, or cells cotransfected 
with separate vectors, pPP and pDHFRr-I 
Transfection Content Secretion 
type PP mole- PP molecules 
cules per cell per cell 
per 24 h 
CHO-wild 
type - 0 0 
CHO-571 a cotransfect. 3.6 × 105 2.6-3.0 × 10 6b 
CHO-727 dicistronic N.D. 5.5 × l05 
CHO-728 a dicistronic 3.8 x 105 0.9-1.1 )< 10 6b 
CHO-731 dicistronic N.D. 1.2 × l05 
a Cell lines in which the DNA and RNA were studied by 
Southern and Northern analysis 
b Secretion studied on two occasions ix months apart 
N.D., not determined 
cubation with labelled amino acid, a somewhat 
larger (15 kDa), labelled peptide is also detected 
(figs 4 and 5); it has not been clarified in the pre- 
sent study whether this reflects a modif ication of  
the PP precursor occurring in the medium or in the 
cells. It should be noted that a glycosylation site is 
found in the precursor at amino acid residues 
Asn-40-A la -Thr -42  [11]. During pulse-chase x- 
periments the precursor was secreted rapidly, 
within 30-45 min, into the medium (fig.5). This 
rapid secretion of  unprocessed precursor is in ac- 
cordance with the fact that the CHO cell is not a 
neuroendocrine cell type, and therefore is not 
capable of  storing peptide precursors and secreting 
them through the so-called regulated pathway [26]. 
4. D ISCUSSION 
We have demonstrated that dicistronic expres- 
sion units can be used to select transformed cell 
lines, If the selectable genetic marker, in this study 
an Mtx-resistant mutant of  DHFR,  is incorporated 
as a second open reading frame on the dicistronic 
mRNA,  this genetic marker is apparently express- 
ed at a sufficiently high efficiency to confer an 
Mtx-resistant phenotype on transformed cells. If a 
cDNA is built into the dicistronic construction as 
a 5 ' -proximal  open reading frame, clones express- 
ing the selectable marker will express the cDNA. 
We have verified by Northern blotting that both 
a.  -i- 
+ 
tO tO lid 
0 0 ~ 
t~ tN v- ~- 




Fig.4. Characterization f immunoreactive PP peptides 
by immunoprecipitation a d SDS-gel electrophoresis. 
Media from cells, clone CHO-728, incubated with ~SS- 
methionine, were extracted by Sep-Pak and 
radiolabelled peptides were immunoprecipitated by two 
PP-antisera, 146-7 and 205, with and without the 
addition of an excess of unlabelled PP. The precipitation 
was performed with an excess protein A-Sepharose. 
Radiolabelled peptides were eluted from the beads with 
SDS sample mixture before electrophoresis in 16070 SDS- 
acrylamide slab gels. The precursor for PP (the 
prohormone) consists of 66 amino acids and migrates 
with an apparent molecular mass of 9500 Da in SDS gels 
[11]. The position of size markers is shown. 
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Fig.5. SDS-gel electrophoresis of immunoprecipitable PP peptides in media from CHO-571 cells during a pulse-chase 
experiment. Ceils were labelled with 35S-methionine for a pulse period of 30 min (lane l) followed by incubation with 
excess amount of unlabelled methionine for 15 min (lane 2), 30 min (lane 3), 60 min (lane 4), 120 min (lane 5), and 
for 210 min (lane 6). 
PP and DHFR are encoded on the same 1.6 kb 
mRNA transcript. Peabody et al. [2,3] confirmed 
that eukaryotic ribosomes can reinitiate translation 
by analysis of translated proteins ynthesized from 
constructed icistronic transcripts, on which two 
open reading frames were positioned in a number 
of different arrangements with respect to each 
other. This possibility had previously been sug- 
gested, e.g. by deletion mutations affecting 
translation in plants of the open reading frames 
VII and I of the cauliflower mosaic virus [27], and 
by analysis of the effects of upstream AUG and 
stop codons on the translation of the hepatitis B 
virus surface antigen [10] and the E. coli galac- 
tokinase gene (galK) [1] in mammalian cells. 
This ability of eukaryotic ribosomes to reinitiate 
translation offers the possibility of designing ex- 
pression units with a close functional and struc- 
tural connection between the DNAs of the 
investigated protein and the selectable marker. The 
fact that expression of a heterologous gene product 
is closely coupled to the expression of a selectable 
genetic marker transcribed from the same pro- 
moter might offer advantages in long term clone 
stability and in the amplification potential of the 
integrated gene. During preparation of our 
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manuscript a similar study on the use of 
polycistronic vectors in the direct selection of 
transfected cell lines was published by Kaufman et 
al. [28]. They used the wild type mouse DHFR as 
a selectable marker in CHO DUKX-B11 cells [29], 
and demonstrated expression of adenosine 
deaminase (ADA) and granulocyte macrophage 
colony stimulating factor (GM-CSF) from 
dicistronic onstructs. In COS cells [30] they also 
demonstrated expression from a tricistronic 
transcript which included the three above- 
mentioned cDNAs. Human plasminogen activator 
cDNA (tPA) has also been expressed [31] from a 
dicistronic construct in CHO DUKX-Bl l  cells, 
and we have obtained expression of human clot- 
ting factor IX (FIX), E. coli chloramphenicol 
acetyltransferase (CAT) and mouse DHFR from 
di- and tricistronic vectors transfected into BHK 
cells (Berkner et al., in preparation). The neomycin 
gene (neo) from Tn5 [32] can be used as well to ob- 
tain stable transformants from polycistronic 
transcripts. Recently we used G418 selection 
together with both di- and tricistronic onstructs 
encoding human neuropeptide Y (NPY) [33], PP 
and neo to obtain stable transformants in the 
neuroendocrine c ll line AtT-20 (Wulff et al., in 
preparation). The growing number of different 
cDNAs of variable nucleotide lengths, which have 
been incorporated into functional eukaryotic 
polycistronic transcription units, argues that this 
concept of expression vector design might have 
general applicability. 
Our original expectations to the performance of 
the dicistronic constructs were that by weakening 
the translation of the selectable genetic marker by 
incorporating it as a second open reading frame on 
a dicistronic mRNA, we would enforce an extra 
hard selection on transfected cells, thereby 
generating ones that transcribed a relatively large 
amount of dicistronic mRNA. This could be ob- 
tained by, e.g., chromosomal integration in 
transcriptionally very active regions of the 
genome, and this would be reflected in a 
reproducibly higher level of product synthesized 
from the 5'-proximal open reading frame. The 
significantly fewer colonies generated with 
polycistronic expression units (approx. 20-fold in 
our study) as compared to the monocistronic type 
shows that expression of the selectable marker is 
impaired. However, we have consistently found no 
higher level of expression from the 5'-proximal 
open reading frame in the di- or tricistronic on- 
structs. Apparently there is still much performance 
evaluation to be done on this new type of 
polycistronic eukaryotic transcription units, before 
their full potential can be evaluated. We have in- 
itiated such work, which will involve, for instance, 
changes in the intercistronic regions, mutations of 
the sequences around initiating AUG codons, gene 
amplification and long term stability studies. The 
results from such studies will be reported elsewhere 
(Berkner et al., in preparation). 
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